United Kingdom Approves the Pfizer and BioNtech COVID-19 Vaccine
The companies are ready to ship doses immediately.
Dealing With a COVID-19 Diagnosis
Mady Hornig, MA, MD, discusses the mental and emotional aspects of dealing with a diagnosis and the evolution of how people are processing the virus many months later after it started.
Can COVID-19 Morph into Other Serious Health Issues?
A team at Columbia University's Mailman School of Public Health is partnering with a chronic fatigue syndrome (CFS) organization to study COVID-19 and CFS.
No Symptoms Shown in Over One-Third of COVID-19 Infected Children
Recent study may have implications for social and public health policies
Overcoming Post-viral Distortions with “Smell Training”
Olfactory dysfunction is a critical loss of information that is important for responding to our environment.
Study Finds How COVID-19 Reaches the Brain
Researchers produce the first-ever electron microscopy images of intact coronavirus particles within olfactory mucosa.
Studying COVID-19 Long-Haulers
A team at Columbia University's Mailman School of Public Health is looking at the long term of effects in some patients who are suffering from this phenomenon.
Important Findings Explain Cause of Fatal Influenza
New study may help contribute to COVID-19 research.
Genetic Variations Reveal Link to COVID-19
Patients with pervasive conditions are found to be more at risk for a severe case of COVID-19.
Insights From a COVID-19 Long Hauler
Mady Hornig, MA, MD, shares her experiences of having lingering effects as part of a phenomenon where some people suffer from the virus over many months.
Will We Be Assured with a COVID-19 Vaccine?
A look at the logistical questions which remain with the two leading candidates.
Fluvoxamine May Prevent Clinical Deterioration in Mild COVID-19
An early trial of fluvoxamine to treat mild coronavirus disease 2019 (COVID-19) showed promising results, suggesting the antidepressant may help ward off clinical deterioration in patients with mild symptoms.
The Risks of COVID-19 Pre-print Data
Articles not undergoing peer review are reaching widespread dissemination during the pandemic. What are the implications?
Mutations of SARS-CoV-2 do not Increase Transmissibility
Researchers find most common mutations appear to have been induced by the human immune system.
Assessing Monoclonal Antibodies for COVID-19 at Keck
A study author at Keck Medicine of USC discusses an ongoing assessment of LY-CoV555 for preventing severe COVID-19, and the overall benefit of the drug class for pandemic mitigation.
Advancing Microbial Stewardship Guidance with Neil Clancy, MD
The IDSA representative discusses advances made in recent years, and how foundational guidance could be set by the FDA with input from specialists.
Mark McLelland, MD, PhD: What We Need to Address COVID-19
The former FDA commissioner weighs in on the best measures to mitigate skyrocketed new cases, and his timeline for national recovery.
Using a Cancer Therapy Platform as a Potential COVID-19 Vaccine
OncoSec recently received an FDA IND clearance to begin a phase 1 trial.
Convalescent Plasma Falls Flat in New Study
Important finding shows convalescent plasma provides no significant benefit in severe COVID-19 cases.
COVID-19 Survivors Improve with Home Health Care
Recent study shows COVID-19 survivors health improves with support of Home Health Care.
Algorithm Predicts COVID-19 Outcomes
An artificial intelligence (AI) algorithm predicts outcomes in patients diagnosed with COVID-19.
Superspreader Events Provide New Insights into SARS-CoV-2
New study provides deep insights into the COVID-19 pandemic.
New Flu Therapy Potentially Effective Against COVID-19
A recently created therapy for the influenza virus may help aid in the fight against COVID-19.
IDSA Releases New Guidelines For COVID-19 Treatment
The guidelines were recently updated to reflect new information on COVID-19 treatment and management.
Baloxavir Indication is Expanded by FDA
The influenza therapy is expanded to include people who have been exposed to the flu.
Evaluation of “Rapid” Antibody Test in Britain Suggests High Number of False Positives
Accuracy of test may be influenced by size of population to be screened and prevalence of COVID-19 within that population.
Analyzing SARS-CoV-2 Replication Through 3D Modeling
New details of SARS-CoV-2 have been obtained using 3D modeling, providing crucial insights into the disease.
Determining the Biomarkers of COVID-19 Outcome and Severity
National Institute of Allergy and Infectious Disease (NIAID) has selected Metabolon to participate in a study on this subject.
AstraZeneca Investigational COVID-19 Vaccine Shown to be 90% Efficacious
Data shows their AZD1222 vaccine met its endpoint and they are preparing regulatory submission for conditional or early approval.
Predicting COVID-19 Mortality
A research team developed an algorithm review estimating not only hospital admissions, but also mortality outcomes in adults with COVID-19.
